RUZURGI
Pre-Launchamifampridine
NDAORALTABLETPriority Review
Lifecycle
Pre-Launch
Clinical Trials
9
Clinical Trials (5)
Pyridostigmine and Amifampridine for Myasthenia Gravis
Started Mar 2023
24 enrolled
Myasthenia Gravis
Long Term Safety of Amifampridine Phosphate in Spinal Muscular Atrophy 3
Started Mar 2019
Controlled Trial to Evaluate Amifampridine Phosphate in Spinal Muscular Atrophy Type 3 Patients
Started Jan 2019
Long Term Safety Study of Amifampridine Phosphate in MuSK-MG (Muscle Specific Tyrosine Kinase Myasthenia Gravis)
Started Jun 2018
Study to Evaluate Amifampridine Phosphate in Patients With MuSK-MG
Started Apr 2018